SARS CoV 2 S glycoprotein, COVID-19 Spike protein, RBD, Receptor Binding Domain, E2 glycoprotein, E2, Human coronavirus 2 spike glycoprotein, Peplomer protein, S glycoprotein, SARS coronavirus 2 S protein, SARS coronavirus 2 Spike Protein, SARS CoV 2 Spi
The original antibody was generated from a panel of humanized single domain antibodies derived from a synthetic library. The antibody was isolated by panning against SARS-CoV-2 spike receptor-binding domain (RBD).